North America accounts for 36.5% of global endoscopy devices revenue in 2025, worth USD 19.78 billion, and the region is projected to reach USD 32.34 billion by 2034. Contrive Datum Insights has published a study of the market that covers five segmentation axes and all five regions, with country-level breakdowns.
Regional Picture
The study sizes the global market at USD 54.2 billion in 2025. It projects USD 57.89 billion in 2026 and USD 97.99 billion by 2034, a compound annual growth rate of 6.8% across the forecast period. Rising volume of gastrointestinal and minimally invasive procedures is the largest single contributor to that growth, and the study rates its impact high.
North America leads, but the other regions do not stand still. Asia Pacific is the one gaining ground, moving from 27% of global revenue in 2025 to 32% in 2034 as its revenue grows from USD 14.63 billion to USD 31.36 billion. Middle East and Africa stays the smallest region, at 5.5% of revenue in 2025 and again in 2034. The United States is the largest single country market at USD 17.41 billion in 2025, or 32.12% of global revenue, so a good deal of North America's weight sits in one country.
By product, Endoscopes hold 42% of 2025 revenue, worth USD 22.76 billion, yet the line grows at only 4.97%. Robot Assisted Endoscopy Devices is the fastest-growing product line at 13.92%; its share of revenue rises from 6% to 11% and its value from USD 3.25 billion to USD 10.78 billion. The other axes show the same pattern of a large incumbent line and a faster challenger:
- Application: Gastrointestinal (GI) endoscopy leads in 2025 with 34% of revenue at USD 18.43 billion, while Bronchoscopy grows fastest at 12.14%.
- End-use: Hospitals lead with 62% of revenue at USD 33.6 billion, while Ambulatory surgery center grows fastest at 9.11%.
- Distribution channel: Direct Tenders lead with 58% of revenue at USD 31.44 billion, while Distributor Sales grows fastest at 7.88%.
- Technology: High Definition (HD) Systems lead with 58% of revenue at USD 31.44 billion, while Ultra HD / 4K Systems grows fastest at 12.83%.
Risk to the Leading Region
Three pressures bear on North America's position. Asia Pacific's rising share is the structural one: a region adding five points of share over the forecast period narrows the distance to the leader even while North America itself keeps growing.
The second is spending. Hospitals account for the largest share of revenue, so a tightening of hospital capital budgets would reach the biggest lines first. In the study's bear case, capital spending tightens and ambulatory procedure migration slows, which delays replacement of existing reusable endoscope fleets and capital equipment upgrades. That path holds 2034 revenue to USD 88.19 billion.
The third is the slow growth of the largest product line. Endoscopes, at 4.97% against the market's 6.8%, cannot carry a region's share on their own. If robot-assisted and single-use platform adoption runs faster than the base case, the study's bull case puts 2034 revenue at USD 109.75 billion, and the regions that adopt first stand to gain most.
The report provides revenue and a growth rate for every line in every year from 2020 to 2034, bear, base and bull scenarios for the headline total, the competitive landscape, and the research methodology behind each estimate. It is delivered as a PDF, and a free sample is available on request.